BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34147315)

  • 21. Cutaneous ulcers associated with hydroxyurea therapy in myeloproliferative disorders.
    Ravandi-Kashani F; Cortes J; Cohen P; Talpaz M; O'Brien S; Markowitz A; Kantarjian H
    Leuk Lymphoma; 1999 Sep; 35(1-2):109-18. PubMed ID: 10512168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggressive, extensive, vasculitic leg ulceration associated with hydroxyurea therapy and a fatal outcome.
    Young HS; Kirby B; Stewart EJ
    Clin Exp Dermatol; 2001 Nov; 26(8):664-7. PubMed ID: 11722451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydroxyurea associated leg ulcer succesfully treated with hyperbaric oxygen in a diabetic patient.
    Akinci B; Yesil S; Atabey A; Ilgezdi S
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):143-5. PubMed ID: 17318777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful treatment of hydroxyurea-associated chronic leg ulcers associated with squamous cell carcinoma.
    Antar A; Ishak RS; Otrock ZK; El-Majzoub N; Ghosn S; Mahfouz R; Taher AT
    Hematol Oncol Stem Cell Ther; 2014 Dec; 7(4):166-9. PubMed ID: 25467031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence of hydroxyurea-induced leg ulcer after discontinuation of treatment.
    Kikuchi K; Arita K; Tateishi Y; Onozawa M; Akiyama M; Shimizu H
    Acta Derm Venereol; 2011 May; 91(3):373-4. PubMed ID: 21336478
    [No Abstract]   [Full Text] [Related]  

  • 26. [A hydroxyurea-induced leg ulceration].
    Lammintausta K; Mäkelä L; Remes K
    Duodecim; 2001; 117(1):31-3. PubMed ID: 12092349
    [No Abstract]   [Full Text] [Related]  

  • 27. Hydroxyurea-induced leg ulcers: is macroerythrocytosis a pathogenic factor?
    Vélez A; García-Aranda JM; Moreno JC
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):243-4. PubMed ID: 10461646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of hydroxyurea-induced leg ulcer after definitive treatment suspension in a patient affected by thrombocythemia: effectiveness of a new collagenase.
    Fioramonti P; Fino P; Parisi P; Scuderi N; Onesti MG
    In Vivo; 2012; 26(6):1053-6. PubMed ID: 23160693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxyurea induced skin ulceration in myeloproliferative disorders.
    McLintock C; Ockelford PA
    Aust N Z J Med; 2000 Jun; 30(3):373-6. PubMed ID: 10914756
    [No Abstract]   [Full Text] [Related]  

  • 30. Leg ulcers and hydroxyurea: forty-one cases.
    Sirieix ME; Debure C; Baudot N; Dubertret L; Roux ME; Morel P; Frances C; Loubeyres S; Beylot C; Lambert D; Humbert P; Gauthier O; Dandurand M; Guillot B; Vaillant L; Lorette G; Bonnetblanc JM; Lok C; Denoeux JP
    Arch Dermatol; 1999 Jul; 135(7):818-20. PubMed ID: 10411157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.
    Chaine B; Neonato MG; Girot R; Aractingi S
    Arch Dermatol; 2001 Apr; 137(4):467-70. PubMed ID: 11295927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ulcers on the legs and feet: a seldom recognised side effect of hydroxyurea].
    Janssen JJ; Ossenkoppele GJ
    Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1517-20. PubMed ID: 12924084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cutaneous side effects of a long-term treatment by hydroxyurea].
    Steels E; Heenen M; Germaux MA; Moens JP
    Rev Med Brux; 2006; 27(1):39-41. PubMed ID: 16608010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
    Tripathi AK; Ahmad R; Sawlani KK
    J Assoc Physicians India; 2003 Oct; 51():1014-5. PubMed ID: 14719596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multidisciplinary team approach to hydroxyurea-associated chronic wound with squamous cell carcinoma.
    Stone T; Berger A; Blumberg S; O'Neill D; Ross F; McMeeking A; Chen W; Pastar I
    Int Wound J; 2012 Jun; 9(3):324-9. PubMed ID: 22099725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus-positive mucocutaneous ulcer in a patient with polycythemia vera treated with oral hydroxyurea.
    Hamada T; Kawata M; Maeda Y; Yoshino T; Miyake T; Morizane S; Hirai Y; Iwatsuki K
    J Dermatol; 2018 Apr; 45(4):e82-e83. PubMed ID: 29139148
    [No Abstract]   [Full Text] [Related]  

  • 37. Repairing of recurrent leg ulcer induced by hydroxyurea with posterior tibial artery perforator propeller flap: Case report.
    Wan ZD; Li WZ
    Int J Surg Case Rep; 2024 Jan; 114():109049. PubMed ID: 38029574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxyurea-related leg ulcers in a patient with chronic myelogenous leukemia: a case report and review of the literature.
    Kato N; Kimura K; Yasukawa K; Yoshida K
    J Dermatol; 1999 Jan; 26(1):56-62. PubMed ID: 10063214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Leg ulcer due to hydroxyurea. A case report].
    Gning SB; Debonne JM; Diagne-Guèye NM; Ndiaye B; Fall F; Mbaye PS
    Dakar Med; 2006; 51(2):89-91. PubMed ID: 17632983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytopenia under topical imiquimod in two patients treated with oral hydroxyurea].
    Joachim C; Gras-Champel V; Marolleau JP; Chaby G; Dairi M; Carmi E
    Ann Dermatol Venereol; 2018 Dec; 145(12):765-768. PubMed ID: 30217687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.